Corticotropin-releasing factor receptor type 1 is involved in the stress-induced exacerbation of chronic contact dermatitis in rats

Experimental Dermatology

Volumn 12, Issue 1, 2003, Pages 47-52

  Kaneko, Katsumi ^a   Kawana, Seiji ^a   Arai, Keiko ^a   Shibasaki, Tamotsu ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

2, 4, 6 trinitro 1 chlorobenzene; Chronic contact dermatitis; Corticotropin releasing factor receptor antagonist; Corticotropin releasing factor receptor type 1; Stress

Indexed keywords

SULFUR; TETRAHYDROFURAN DERIVATIVE; THIOPHANATE METHYL;

ACCURACY; ARTICLE; CHEMICAL ANALYSIS; CHEMICAL REACTION KINETICS; QUANTITATIVE ANALYSIS; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SENSITIVITY AND SPECIFICITY; SEPARATION TECHNIQUE; ULTRAVIOLET RADIATION; VALIDATION PROCESS;

ANIMALS; CHRONIC DISEASE; DERMATITIS, CONTACT; DERMIS; ELECTROSHOCK; EPIDERMIS; FOOT; IMMUNOGLOBULIN E; MALE; MAST CELLS; PICRYL CHLORIDE; PYRIDINES; PYRIMIDINES; RATS; RATS, WISTAR; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; STRESS;

EID: 0042031542     PISSN: 09066705     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0625.2003.120106.x     Document Type: Article

References (36)

1. Rivier C, Rivier J E, Vale W. Inhibition of adrenocorticotropic hormone secretion in the rat by immunoneutralization of corticotropin-releasing factor. Science 1982: 218: 377-379.
2. Opp M R. Corticotropin-releasing hormone involvement in stressor-induced alterations in sleep and in the regulation of waking. Adv Neuroimmunol 1995: 5: 127-143.
3. Stephens R L Jr, Yang H, Rivier J, Tache Y. Intracisternal injection of CRF antagonist blocks surgical stress-induced inhibition of gastric secretion in the rat. Peptides 1988: 9: 1067-1070.
4. Williams C L, Peterson J M, Villar R G, Burks T F. Corticotropin-releasing factor directly mediates colonic responses to stress. Am J Physiol 1987: 253: G582-G586.
5. Shibasaki T, Yamauchi N, Hotta M et al. Brain corticotropin-releasing factor acts as inhibitor of stress-induced gastric erosion in rats. Life Sci 1990: 47: 925-932.
6. Kahn D D, Gosnell B A, Levine A S, Morley J E. Behavioral effects of corticotropin-releasing factor: Localization and characterization of central effects. Brain Res 1988: 443: 63-69.
7. Shibasaki T, Yamauchi N, Kato Y et al. Involvement of corticotropin-releasing factor in restraint stress-induced anorexia and reversion of the anorexia by somatostatin in the rat. Life Sci 1988: 43: 1103-1110.
8. Rivier C, Rivier J, Vale W. Stress-induced inhibition of reproductive functions: Role of endogenous corticotropin-releasing factor. Science 1986: 231: 607-609.
9. Irwin M, Vale W, Rivier C. Central corticotropin-releasing factor mediates the suppressive effect of stress on natural killer cytotoxicity. Endocrinology 1990: 126: 2837-2844.
10. Irwin M. Brain corticotropin-releasing hormone- and interleukin-1b-induced suppression of specific antibody production. Endocrinology 1993: 133: 1352-1360.
11. Jain R, Zwickler D, Hollander C S et al. Corticotropin-releasing factor modulates the immune response to stress in the rat. Endocrinology 1991: 128: 1329-1336.
12. Shibasaki T, Hotta M, Sugihara H, Wakabayashi I. Brain vasopressin is involved in stress-induced in suppression of immune function in the rat. Brain Res 1998: 808: 84-92.
13. Shibasaki T, Yamauchi N, Hotta M et al. Brain corticotropin-releasing hormone increases arousal in stress. Brain Res 1991: 554: 352-354.
14. Tazi A, Dantzer R, Le Moal M, Rivier J, Vale W, Koob G F. Corticotropin-releasing factor antagonist blocks stress-induced fighting in rats. Regul Pept 1987: 18: 37-42.
15. Grigoriadis D E, Lovenberg T W, Chalmers D T, Liaw C, De Souza E B. Characterization of corticotropin-releasing factor receptor subtypes. Ann N Y Acad Sci 1996: 780: 60-80.
16. Lundkvist J, Chai Z, Teheranian R et al. A non peptidic corticotropin releasing factor receptor antagonist attenuates fever and exhibits anxiolytic-like activity. Eur J Pharmacol 1996: 309: 195-200.
17. Schulz D W, Mansbach R S, Sprouse J et al. CP-154,526: A potent and selective nonpeptide antagonist of corticotropin releasing factor receptors. Proc Natl Acad Sci USA 1996: 93: 10477-10482.
18. Baram T Z, Chalmers D T, Chen C, Koutsoukos Y, De Souza E B. The CRF1 receptor mediates the excitatory actions of corticotropin releasing factor (CRF) in the developing rat brain: In vivo evidence using a novel, selective, non-peptide CRF receptor antagonist. Brain Res 1997: 770: 89-95.
19. Hotta M, Shibasaki T, Arai K, Demura H. Corticotropin-releasing factor receptor type 1 mediates emotional stress-induced inhibition of food intake and behavioral changes in rats. Brain Res 1999: 823: 221-225.
20. Roloff B, Fechner K, Slominski A et al. Hair cycle-dependent expression of corticotropin-releasing factor (CRF) and CRF receptors in murine skin. FASEB J 1998: 12: 287-297.
21. Slominski A, Ermak G, Mazurkiewicz J E, Baker J, Wortsman J. Characterization of corticotropin-relasing hormone (CRH) in human skin. J Clin Endocrinol Metab 1998: 93: 1020-1024.
22. Slominski A, Ermak G, Hwang J, Chakraborty A, Mazurkiewicz J E, Mihm M. Proopiomelanocortin, corticotropin releasing hormone and corticotropin releasing hormone receptor genes are expressed in human skin. FEBS Lett 1995: 374: 113-116.
23. Slominski A, Ermak G, Hwang J, Mazurkiewicz J, Corliss D, Eastman A. The expression of proopiomelanocortin (POMC) and of corticotropin releasing hormone receptor (CRH-R) genes in mouse skin. Biochim Biophys Acta 1996: 1289: 247-251.
24. Funasaka Y, Sato H, Chakraborty A K, Ohashi A, Chrousos G P, Ichihashi M. Expression of proopiomelanocortin, corticotropin-releasing hormone (CRH), and CRH receptor in melanoma cells, nevus cells, and normal human melanocytes. J Invest Dermatol Symp Proc 1999: 4: 105-109.
25. Slominski A, Wortsman J, Pisarchik A et al. Cutaneous expression of corticotropin-releasing hormone (CRH), urocortin, and CRH receptors. FASEB J 2001: 15: 1678-1693.
26. Slominski A, Wortsman J, Luger T, Paus R, Solomon S. Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress. Physiol Rev 2000: 80: 979-1020.
27. Arai K, Ohata H, Shibasaki T. Non-peptidic corticotropin-releasing hormone receptor type 1 antagonist reverses restraint stress-induced shortening of sodium pentobarbital-induced sleeping time of rats: Evidence that an increase in arousal induced by stress is mediated through CRH receptor type 1. Neurosci Lett 1998: 255: 103-106.
28. Theoharides T C, Singh L K, Boucher W et al. Corticotropin-releasing hormone induces skin mast cell degranulation and increased vascular permeability, possible explanation for its proinflammatory effects. Endocrinology 1998: 139: 403-413.
29. Singh L K, Boucher W, Pang X et al. Potent mast cell degranulation and vascular permeability triggered by urocortin through activation of corticotropin-releasing hormone receptors. J Pharmacol Exp Ther 1999: 288: 1349-1356.
30. Gniadecki R. Regulation of keratinocyte proliferation. General Pharmacol 1998: 30: 619-622.
31. Alexacos N, Pang X, Boucher W, Cochrane D E, Sant G R, Theoharides T C. Neurotensin mediates rat bladder mast cell degranulation triggered by acute psychological stress. Urology 1999: 53: 1035-1040.
32. Pang X, Alexacos N, Letourneau R et al. A neurotensin receptor antagonist inhibits acute immobilization stress-induced cardiac mast cell degranulation, a corticotropin-releasing hormone-dependent process. J Pharmacol Exp Ther 1998: 287: 307-314.
33. Herrscher R F, Kasper C, Sullivan T J. Endogenous cortisol regulates immunoglobulin E-dependent late phase reactions. J Clin Invest 1992: 90: 596-603.
34. Udelsman R, Harwood J P, Millan M A et al. Functional corticotropin releasing factor receptors in the primate peripheral sympathetic nervous system. Nature 1986: 319: 147-150.
35. Parronchi P, Macchia D, Piccinni M P et al. Allergen- and bacterial antigen-specific T-cell clones established from atopic donors show a different profile of cytokine production. Proc Natl Acad Sci USA 1991: 88: 4538-4542.
36. Juhlin L, Johansson S G O, Bennich H, Högman C, Thyresson N. Immunoglobulin E in dermatoses: Levels in atopic dermatitis and urticaria. Arch Dermatol 1969: 100: 12-16.